Table 3.
Battle Viro Intervention | Control | Effect Size Difference (di –dc)c |
|||||||
---|---|---|---|---|---|---|---|---|---|
Pretest | Post a | Pretest | Posta | ||||||
d b | d b | F d | p | ||||||
Log Viral Load (M (SD)) | 3.63 (1.11) | 0.93 (1.63) | −2.74 | 3.94 (0.90) | 1.53 (2.49) | −0.53 | −2.21 | 4.33 | 0.04 |
Wisepill 7-day Adherence
(M (SD)) |
0.70 (0.35) | 0.71 (0.32) | 0.03 | 0.86 (0.17) | 0.48 (0.44) | −1.12 | 1.15 | 3.90 | 0.05 |
Self-Report 7-day Adherence (M (SD)) |
0.96 (0.09) | 0.88 (0.31) | −0.35 | 0.97 (0.06) | 0.91 (0.30) | −0.27 | −0.08 | 0.05 | 0.82 |
HIV Knowledge (M (SD)) | 2.27 (0.79) | 2.91 (1.45) | 0.55 | 2.90 (0.94) | 2.55 (1.13) | −0.35 | 0.90 | 0.52 | 0.47 |
ART Treatment Knowledge (M (SD)) |
11.82 (3.46) | 13.18 (1.94) | 0.47 | 12.45 (1.81) | 11.63 (4.23) | −0.25 | 0.72 | 0.42 | 0.52 |
Motivation for ART
(M (SD)) |
13.18 (3.22) | 12.00 (4.12) | −0.32 | 10.70 (4.19) | 12.20 (3.52) | 0.39 | −0.71 | 0.39 | 0.53 |
Self-Efficacy for ART Skills (M (SD)) |
19.18 (3.71) | 19.09 (5.65) | −0.02 | 18.36 (5.51) | 19.36 (3.64) | 0.21 | −0.23 | 0.56 | 0.46 |
Social Support
(M (SD)) |
27.64 (3.32) | 27.64 (5.18) | 0 | 25.45 (2.94) | 25.00 (4.02) | −0.13 | 0.13 | 0.03 | 0.87 |
: 16-weeks post-baseline
: Cohen’s d
: Cohen’s d effect size difference (Battle Viro - Control)
: ANCOVA interaction statistic between intervention condition and newly starting ARV in past 3 months in entire sample, controlling for baseline